UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Back on Track to Healthy Living Study

Not Applicable

Completed

Conditions: Chronic Pain

Interventions: Behavioral: Cognitive Therapy (CT)
Behavioral: Activation Skills (AS)
Behavioral: Mindfulness Meditation (MM)

First Posted Date: 2018-09-27

Last Posted Date: 2024-02-21

Lead Sponsor: University of Washington

Target Recruit Count: 397

Registration Number: NCT03687762

Locations: 🇺🇸
University of Washington, Ninth and Jefferson Building, Seattle, Washington, United States

Socially Isolated Older Adults Living With Dementia

Not Applicable

Completed

Conditions: Dementia
Alzheimer Disease

Interventions: Behavioral: Personalized care network

First Posted Date: 2018-09-12

Last Posted Date: 2022-02-02

Lead Sponsor: University of Washington

Target Recruit Count: 30

Registration Number: NCT03666624

Locations: 🇺🇸
UWashington, Seattle, Washington, United States

Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomas

Phase 1

Active, not recruiting

Conditions: Metastatic Soft Tissue Sarcoma
Advanced Soft Tissue Sarcoma
Locally Advanced Soft Tissue Sarcoma

Interventions: Drug: Sirolimus Albumin-bound Nanoparticles
Drug: Pazopanib hydrochloride

First Posted Date: 2018-09-07

Last Posted Date: 2024-03-13

Lead Sponsor: University of Washington

Target Recruit Count: 19

Registration Number: NCT03660930

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

A Community Wellness Program for Adults Living With Long-term Physical Disability

Not Applicable

Completed

Conditions: Physical Disability

Interventions: Behavioral: EnhanceWellness for Disability (EW-D)
Behavioral: Wellness Education

First Posted Date: 2018-08-31

Last Posted Date: 2023-11-21

Lead Sponsor: University of Washington

Target Recruit Count: 516

Registration Number: NCT03653390

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer

Phase 2

Terminated

Conditions: Stage IV Prostate Cancer AJCC v8
Metastatic Malignant Neoplasm in the Bone
Metastatic Prostate Carcinoma
Prostate Adenocarcinoma
Prostate Small Cell Neuroendocrine Carcinoma
Stage IVA Prostate Cancer AJCC v8
Stage IVB Prostate Cancer AJCC v8
Castration-Sensitive Prostate Carcinoma

Interventions: Drug: Antiandrogen Therapy
Drug: Abiraterone Acetate
Drug: Prednisone
Radiation: Radiation Therapy

First Posted Date: 2018-08-28

Last Posted Date: 2023-10-26

Lead Sponsor: University of Washington

Target Recruit Count: 10

Registration Number: NCT03649841

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Effect of Pembrolizumab and Cisplatin on Metastatic, Locally Recurrent or Inoperable Triple-Negative Breast Cancer

Phase 2

Withdrawn

Conditions: HER2/Neu Negative
Recurrent Breast Carcinoma
Estrogen Receptor Negative
Metastatic Breast Cancer
Progesterone Receptor Negative
Triple Negative Breast Cancer

Interventions: Biological: Pembrolizumab
Drug: Cisplatin

First Posted Date: 2018-08-23

Last Posted Date: 2019-04-26

Lead Sponsor: University of Washington

Registration Number: NCT03644589

Locations: 🇺🇸
Seattle Cancer Care Alliance, Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors

Not Applicable

Terminated

Conditions: Ovarian Cancer
Fallopian Tube Transitional Cell Carcinoma
Fallopian Tube Undifferentiated Carcinoma
Ovarian Transitional Cell Carcinoma
Fallopian Tube Adenocarcinoma
Fallopian Tube Carcinosarcoma
Fallopian Tube Clear Cell Adenocarcinoma
Ovarian Mucinous Adenocarcinoma
Primary Peritoneal Transitional Cell Carcinoma
Fallopian Tube Serous Adenocarcinoma

Interventions: Other: Exercise Counseling
Other: Aerobic Exercise
Other: Physiological Support
Other: Best Practice
Other: Quality-of-Life Assessment
Other: Questionnaire Administration

First Posted Date: 2018-08-22

Last Posted Date: 2023-11-29

Lead Sponsor: University of Washington

Target Recruit Count: 64

Registration Number: NCT03641287

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Gent for Pharyngeal Gonorrhea (GC)

Phase 2

Terminated

Conditions: Pharyngeal Gonococcal Infection

Interventions: Drug: gentamicin 360mg IM

First Posted Date: 2018-08-15

Last Posted Date: 2020-08-10

Lead Sponsor: University of Washington

Target Recruit Count: 13

Registration Number: NCT03632109

Locations: 🇺🇸
Public Health -- Seattle & King County STD Clinic, Seattle, Washington, United States

Subgroups of Older Adults With Back Pain and Multiple Chronic Conditions

Completed

Conditions: Anxiety
Low Back Pain
Osteoarthritis
Depression

First Posted Date: 2018-08-15

Last Posted Date: 2019-08-19

Lead Sponsor: University of Washington

Target Recruit Count: 8344

Registration Number: NCT03632122

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Non-contrast DWI for Supplemental Screening

Active, not recruiting

Conditions: Breast Cancer

Interventions: Device: Non-contrast MRI
Device: Non-contrast DWI

First Posted Date: 2018-07-31

Last Posted Date: 2024-10-21

Lead Sponsor: University of Washington

Target Recruit Count: 269

Registration Number: NCT03607552

Locations: 🇺🇸
Seattle Cancer Care Alliance, Seattle, Washington, United States
🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy